Table 3.

Summary of different studies of MERS-CoV in camels

Country of study	Date of sampling	Test	Number tested	Number positive	% positive	Refs
Oman	2013	Serology	50	50	100	[27]
Spain (Canary Islands)	2012–2013	Serology	195	15	14	[27]
Qatar	17 October 2013	Neutralization assay	14	14	100	[28]
		PCR	14	3	21	[28]
Egypt	June 2013	Serology	110	103	94	[29]
Saudi Arabia (Al-Hasa & Riyadh)	2010–2013	Serology	310	280	90	[30]
UAE	2003	Serology	151	151	100	[31]
	2013	Serology	500	481	96	[31]
KSA (Jeddah)	2014	PCR	9	2	22.2	[32]
Egypt	June–December 2013	Pseudoparticle neutralization assay	52	48	92.3	[33]
		PCR	110	4	3.6	[33]
Oman	December 2013	PCR	76	5	6.6	[34]
UAE	February–October 2005	Neutralization test	11	9	81.8	[35]
USA, Canada	2000–2001	Neutralization test	6	0	0	[35]
Ethiopia	2010–11	Serology	188	181	96	[36]
Nigeria	2010–2011	Serology	358	336	94	[36]
Tunisia	2010–2011	Serology	204	99	48.5	[36]
Jordan	June and September 2013	Serology	11	11	100	[37]
Kenya	1993–2013	Serology	774	213	27.5	[88]
Egypt	1997	Serology	43	35	81.4	[89]
Sudan	1983	Serology	60	52	86.7	[89]
Somalia	1983	Serology	25	20	80	[89]
Somalia	1984	Serology	61	52	85.2	[89]